Case Reports in Endocrinology · 2015 · 22 citations · 7 references
MedicineOrthopaedic SurgeryOrthopedic SurgeryBone MetabolismOrthopaedic OncologyOrthopedic OncologyBone DisordersBone DysplasiasBone Metabolism DisordersBone PathologyDysplasiaSkeletal DysplasiasBisphosphonate Effects On ResorptionBone Resorption MarkersFemur FracturesMccune-albright SyndromeMissense MutationsMonostotic Fibrous DysplasiaPolyostotic Fibrous DysplasiaRare Bone Diseases
Aim. Fibrous dysplasia is a rare bone disease caused by missense mutation leading to abnormal fibroblast and osteoblast proliferation and increased bone resorption. FD can present in monostotic or polyostotic forms. About 3% of FD could be in association with McCune-Albright syndrome (MAS). Because FD is a rare disease, there is limited data in the literature about characteristics of disease and response to treatment. Methods. We present our five cases of FD with general properties and their responses to medical treatment. Results. Two of our patients had polyostotic and three had monostotic FD. One of the polyostotic patients had MAS. One of our patients had surgery for femur fractures, facial asymmetry, and findings of compression. Four patients were given pamidronate; one was given zoledronic acid as bisphosphonate treatment. Bone pain was relieved in all patients with medical treatment. Conclusion. There was a decrease in bone turnover markers to some degree with medical treatment but no radiological improvement was observed.
7
Louis Lichtenstein · Archives of Surgery · 1938 · 625 citations
Medicine, Pathology, Bone Metabolism +16
Alison M. Boyce, Marilyn H Kelly, Beth A Brillante et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 158 citations · Full text